BIRC5 and prostate cancer: Results demonstrated that isoalantolactone effectively inhibited the proliferation of prostate cancer cells through induction of apoptosis, which is mediated through ROS generation, mitochondrial dysfunction, down-regulation of survivin, and activation of caspase-3.